Company / PP&E (Net)
Omnicell PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$120.1M
FY2025
5-year range
$71.1M / $120.1M
FY2021-FY2025
Trend
+6.6%
vs FY2024
Sector context
#76 of 130
Health Care
What the data says
At $120M, Omnicell's pp&e (net) ranks #76 of 130 in the Health Care sector. PP&E (Net) has increased for 9 consecutive years, from $32M in FY2016 to $120M in FY2025.
Based on SEC 10-K filings.
$120M in FY2025 with a 5-year CAGR of +15.2%.
Improved from $109M to $120M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +15.2%
- 10-Year CAGR
- -
Sector benchmark
#76 of 130 in Health CareTop 58% of 130This company $120.1M Sector average $1.3B
▼
-91.1% below sector average
Key checks
Key Insights
- Omnicell's pp&e (net) has grown for 9 consecutive years.
- 5-year CAGR of +15.2%, indicating consistent growth.
- In FY2025, pp&e (net) increased 6.6% year-over-year.
- Ranks #76 out of 130 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $120.1M | +6.6% |
| FY2024 | $112.7M | +3.8% |
| FY2023 | $108.6M | +15.6% |
| FY2022 | $94.0M | +32.1% |
| FY2021 | $71.1M | +20.4% |
| FY2020 | $59.1M | +8.9% |
| FY2019 | $54.2M | +5.3% |
| FY2018 | $51.5M | +20.9% |
| FY2017 | $42.6M | +31.8% |
| FY2016 | $32.3M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026